Cargando…
CircMED13L_012 promotes lung adenocarcinoma progression by upregulation of MAPK8 mediated by miR-433-3p
BACKGROUND: Metastasis and disease refractoriness remain as major challenges for non-small cell lung cancer (NSCLC) treatment and understanding the underlying molecular mechanisms is of scientific and clinical value. Therefore, in this study, we aimed to explore the effects of circMED13L_012 on the...
Autores principales: | Chen, Wenshu, Zheng, Guanying, Huang, Jianyuan, Zhu, Lihuan, Li, Wujin, Guo, Tianxing, Huang, Yangyun, Pan, Xiaojie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885357/ https://www.ncbi.nlm.nih.gov/pubmed/33593390 http://dx.doi.org/10.1186/s12935-021-01811-4 |
Ejemplares similares
-
TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1
por: Guo, Tianxing, et al.
Publicado: (2022) -
TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma
por: Lin, Zhaoxian, et al.
Publicado: (2020) -
circRNA circMED27 acts as a prognostic factor and mediator to promote lenvatinib resistance of hepatocellular carcinoma
por: Zhang, Pengfei, et al.
Publicado: (2021) -
LncRNA GAS5 inhibits Invasion and Migration of Lung Cancer through influencing EMT process
por: Zhu, Lihuan, et al.
Publicado: (2021) -
Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study
por: Lin, Wenbao, et al.
Publicado: (2022)